Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes Author Name Yehuda Handelsman Category Computer science, information & general works Type Journal Tags Canagliflozin,Cardiovascular effects,Dapagliflozin,Early treatment,Empagliflozin,Ertugliflozin,GLYCEMIC CONTROL,Renal effects,Sodium-glucose cotransporter-2 inhibitors,Type 2 diabetes Login to Access Content
